TNF Inhibition for Alzheimer's Dementia Falls Short TNF Inhibition for Alzheimer's Dementia Falls Short

Weekly subcutaneous etanercept proves safe in AD dementia, with a hint of benefit on psychiatric but not cognitive symptoms in a proof-of-concept phase 2 trial. Further study is planned. Medscape Medical News

Source: Medscape Psychiatry Headlines - June 5, 2015 Category: Psychiatry Tags: Neurology & Neurosurgery News Source Type: news